A study evaluated agreement between 10 AI digital pathology tools in assessing IHC-based HER2 expression and found the most variability in identifying HER2-low samples.
Abstract: This study compares eight machine learning models for lung cancer detection developed between 2021 and 2024, evaluating their architectures, methodologies, and performance metrics. Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results